Integra LifeSciences Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Integra LifeSciences (IART) Misses Q3 EPS by 2c; Lowers Outlook
October 26, 2017 6:10 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.45, $0.02 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $278.8 million versus the consensus estimate of $286.33 million.
GUIDANCE:
Integra LifeSciences sees FY2017 EPS of $1.83-$1.87, versus the consensus of... More
